Sfoglia per Autore
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy
2012-01-01 GP Caviglia; A D'Avolio; A Ciancio; A De Nicolò; L Boglione; ML Abate; C Rosso; A Smedile; G Cariti; J Cusato; M Simiele; M Rizzetto; G Di Perri
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients
2012-01-01 A. D'Avolio;A. De Nicolò;M. Simiele;S. Turini;D. Agnesod;L. Boglione;J. Cusato;L. Baietto;G. Cariti;A. Calcagno;M. Sciandra;G. Di Perri;S. Bonora
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes.
2013-01-01 Boglione L;D'Avolio A;Cariti G;Milia MG;Simiele M;De Nicolò A;Ghisetti V;Di Perri G
Early ribavirin concentration is a critical response factor in the sub-population of patients infected by HCV-1 and unfavourable IL28B genotype
2013-01-01 Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Francesca Patti; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio
Early ribavirin plasma concentrations as predictor of anemia onset after one month of anti-HCV therapy in ITPA stratified population
2013-01-01 Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio
Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs?
2013-01-01 Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients.
2013-01-01 D'Avolio, Antonio; DE NICOLO', Amedeo; Cusato, Jessica; Ciancio, Alessia; Boglione, Lucio; Strona, Silvia; Cariti, G; Troshina, G; Caviglia, GIAN PAOLO; Smedile, Antonina; Rizzetto, Mario; DI PERRI, Giovanni
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
2013-01-01 D'Avolio A;De Nicolò A;Agnesod D;Simiele M;Mohamed Abdi A;Dilly Penchala S;Boglione L;Cariti G;Di Perri G
The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia
2014-01-01 A. De Nicolò;A. Ciancio;L. Boglione;A. Mohamed Abdi;A. Smedile;G.P. Caviglia;G. Di Perri;M. Rizzetto;A. D’Avolio
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner.
2014-01-01 DE NICOLO', Amedeo; Boglione, Lucio; Ciancio, Alessia; Cusato, Jessica; Strona, Silvia; Cardellino, Cs; Abdi, Am; Cariti, G; Troshina, G; Caviglia, GIAN PAOLO; Smedile, Antonina; Rizzetto, Mario; DI PERRI, Giovanni; D'Avolio, Antonio
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients
2014-01-01 Agnesod, D; DE NICOLO', Amedeo; Simiele, Marco; Mohamed Abdi, A; Boglione, Lucio; DI PERRI, Giovanni; D'Avolio, Antonio
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens.
2014-01-01 De Nicolò A;Simiele M;Calcagno A;Mohamed Abdi A;Bonora S;Di Perri G;D'Avolio A
Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period
2014-01-01 Calvo PL; Pinon M; Canaparo R; D’Avolio A; Brunati A; Pensi D; De Nicolò A; Carbonaro G; Cerrina A; Nonnato A; Romagnoli R; Barbera C; Salizzoni M
Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy
2014-01-01 L. Boglione; A. De Nicolò; C. S. Cardellino; T. Ruggiero; V. Ghisetti; G. Cariti; G. Di Perri; A. D’Avolio
Development and validation of an UPLC MS-MS method for the quantification of new direct antiretroviral agents simeprevir, daclatasvir sofosbuvir and its metabolite GS-332007 in human plasma
2014-01-01 Ariaudo A; Simiele M; De Nicolò A; Boglione L; Di Perri G; D'Avolio A
Pharmacokinetic of doxorubicin during chemotherapy in HIV patients affected by Hodgkin disease and Non- Hodgkin’s Lymphoma: the PKCT study
2014-01-01 A. Carbone; A. Calcagno; M. Guffanti; A. D'Avolio; L. Galli; A. De Nicolo; A. Galli; V. Castagna; A. Lazzarin; A. Castagna; N. Gianotti; S. Bonora
An UPLC MS/MS method coupled with automated on-line solid phase extraction for quantification of tacrolimus in PBMC samples
2014-01-01 Pensi D; De Nicolò A; Pinon M; Calvo PL; Di Perri G; D'Avolio A
Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E.
2014-01-01 Boglione L;Cardellino CS;De Nicolò A;Cariti G;Di Perri G;D'Avolio A
Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration
2014-01-01 Pinon M; Calvo PL; D’Avolio A; Pensi D; Brunati A; Canaparo R; De Nicolò A; Carbonaro G; Cerrina A; Di Perri G; Romagnoli R; Barbera C; Salizzoni M
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop
2014-01-01 A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy | 2012 | GP Caviglia; A D'Avolio; A Ciancio; A De Nicolò; L Boglione; ML Abate; C Rosso; A Smedile; G Cariti; J Cusato; M Simiele; M Rizzetto; G Di Perri | |
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients | 2012 | A. D'Avolio;A. De Nicolò;M. Simiele;S. Turini;D. Agnesod;L. Boglione;J. Cusato;L. Baietto;G. Cariti;A. Calcagno;M. Sciandra;G. Di Perri;S. Bonora | |
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. | 2013 | Boglione L;D'Avolio A;Cariti G;Milia MG;Simiele M;De Nicolò A;Ghisetti V;Di Perri G | |
Early ribavirin concentration is a critical response factor in the sub-population of patients infected by HCV-1 and unfavourable IL28B genotype | 2013 | Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Francesca Patti; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio | |
Early ribavirin plasma concentrations as predictor of anemia onset after one month of anti-HCV therapy in ITPA stratified population | 2013 | Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio | |
Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs? | 2013 | Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora | |
Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. | 2013 | D'Avolio, Antonio; DE NICOLO', Amedeo; Cusato, Jessica; Ciancio, Alessia; Boglione, Lucio; Strona, Silvia; Cariti, G; Troshina, G; Caviglia, GIAN PAOLO; Smedile, Antonina; Rizzetto, Mario; DI PERRI, Giovanni | |
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. | 2013 | D'Avolio A;De Nicolò A;Agnesod D;Simiele M;Mohamed Abdi A;Dilly Penchala S;Boglione L;Cariti G;Di Perri G | |
The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia | 2014 | A. De Nicolò;A. Ciancio;L. Boglione;A. Mohamed Abdi;A. Smedile;G.P. Caviglia;G. Di Perri;M. Rizzetto;A. D’Avolio | |
Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner. | 2014 | DE NICOLO', Amedeo; Boglione, Lucio; Ciancio, Alessia; Cusato, Jessica; Strona, Silvia; Cardellino, Cs; Abdi, Am; Cariti, G; Troshina, G; Caviglia, GIAN PAOLO; Smedile, Antonina; Rizzetto, Mario; DI PERRI, Giovanni; D'Avolio, Antonio | |
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients | 2014 | Agnesod, D; DE NICOLO', Amedeo; Simiele, Marco; Mohamed Abdi, A; Boglione, Lucio; DI PERRI, Giovanni; D'Avolio, Antonio | |
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens. | 2014 | De Nicolò A;Simiele M;Calcagno A;Mohamed Abdi A;Bonora S;Di Perri G;D'Avolio A | |
Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period | 2014 | Calvo PL; Pinon M; Canaparo R; D’Avolio A; Brunati A; Pensi D; De Nicolò A; Carbonaro G; Cerrina A; Nonnato A; Romagnoli R; Barbera C; Salizzoni M | |
Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy | 2014 | L. Boglione; A. De Nicolò; C. S. Cardellino; T. Ruggiero; V. Ghisetti; G. Cariti; G. Di Perri; A. D’Avolio | |
Development and validation of an UPLC MS-MS method for the quantification of new direct antiretroviral agents simeprevir, daclatasvir sofosbuvir and its metabolite GS-332007 in human plasma | 2014 | Ariaudo A; Simiele M; De Nicolò A; Boglione L; Di Perri G; D'Avolio A | |
Pharmacokinetic of doxorubicin during chemotherapy in HIV patients affected by Hodgkin disease and Non- Hodgkin’s Lymphoma: the PKCT study | 2014 | A. Carbone; A. Calcagno; M. Guffanti; A. D'Avolio; L. Galli; A. De Nicolo; A. Galli; V. Castagna; A. Lazzarin; A. Castagna; N. Gianotti; S. Bonora | |
An UPLC MS/MS method coupled with automated on-line solid phase extraction for quantification of tacrolimus in PBMC samples | 2014 | Pensi D; De Nicolò A; Pinon M; Calvo PL; Di Perri G; D'Avolio A | |
Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E. | 2014 | Boglione L;Cardellino CS;De Nicolò A;Cariti G;Di Perri G;D'Avolio A | |
Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration | 2014 | Pinon M; Calvo PL; D’Avolio A; Pensi D; Brunati A; Canaparo R; De Nicolò A; Carbonaro G; Cerrina A; Di Perri G; Romagnoli R; Barbera C; Salizzoni M | |
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop | 2014 | A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile